Atlas Trials

Fulcrum Therapeutics

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fulcrum Therapeutics

RecordFirmDate
Open-Label Extension Study to Pioneer Study 6058-SCD-101 (NCT07401823)Fulcrum Therapeutics2026-03-30
Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease (NCT07431398)Fulcrum Therapeutics2025-12-13
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) (NCT05397470)Fulcrum Therapeutics2022-06-16
Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets (NCT05002231)Fulcrum Therapeutics2021-08-19
Safety, Tolerability and Pharmacokinetics of FTX-6058 (NCT04586985)Fulcrum Therapeutics2020-10-26
Losmapimod Safety and Efficacy in COVID-19 (NCT04511819)Fulcrum Therapeutics2020-08-28
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) (NCT04264442)Fulcrum Therapeutics2020-02-13
Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension (NCT04004000)Fulcrum Therapeutics2019-08-23
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT04003974)Fulcrum Therapeutics2019-08-09

Track Fulcrum Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.